time
accur
sensit
detect
infecti
diseas
agent
still
difficult
today
despit
long
histori
progress
area
tradit
method
cultur
antibodybas
detect
still
play
central
role
microbiolog
laboratori
despit
problem
delay
diseas
present
diagnosi
limit
number
organ
detect
approach
hitormiss
natur
diagnost
process
depend
clinic
predict
infecti
sourc
faster
diagnosi
infect
would
reduc
morbid
mortal
exampl
earlier
implement
appropri
antimicrobi
treatment
past
decad
variou
method
propos
achiev
base
nucleic
acid
detect
includ
pcr
microarraybas
techniqu
seem
promis
approach
begin
rapidli
decreas
laboratori
turnaround
time
result
avail
within
hour
compar
perhap
hour
futur
develop
may
see
reduc
even
develop
pointofcar
devic
perhap
enabl
clinician
make
diagnosi
directli
bedsid
pathogen
microarray
util
discov
emerg
infecti
diseas
sar
describ
technic
problem
relat
accuraci
sensit
assay
prevent
routin
use
patient
care
microarray
becom
standard
diagnost
tool
follow
question
must
address
factor
influenc
probe
design
perform
pathogen
signatur
measur
detect
specif
sensit
optim
detect
platform
detect
algorithm
distinguish
coinfect
pathogen
close
relat
viral
strain
noisi
signal
caus
crosshybrid
artifact
present
major
obstacl
interpret
microarray
data
particularli
identif
rare
pathogen
sequenc
present
complex
mixtur
nucleic
acid
exampl
clinic
specimen
contamin
nucleic
acid
sequenc
deriv
host
tissu
crosshybrid
pathogenspecif
microarray
probe
threshold
sequenc
complementar
result
falseposit
signal
lead
erron
conclus
similarli
pathogen
sequenc
addit
bind
specif
probe
may
crosshybrid
nontarget
probe
probe
design
detect
pathogen
latter
phenomenon
though
seemingli
problemat
could
provid
use
inform
pathogen
identif
extent
crosshybrid
accur
predict
variou
metric
assess
anneal
potenti
sequenc
specif
microarray
probe
tradit
design
ensur
maxim
specif
hybrid
known
target
minim
crosshybrid
nonspecif
sequenc
howev
practic
found
mani
probe
though
design
use
optim
silico
paramet
perform
accord
expect
reason
unclear
cw
wong
et
al
unpublish
data
report
result
systemat
investig
complex
relationship
viral
amplif
effici
hybrid
signal
output
targetprob
anneal
specif
reproduc
pathogen
detect
use
custom
design
microarray
platform
find
form
basi
novel
methodolog
silico
predict
pathogen
signatur
shed
light
factor
govern
viral
amplif
effici
demonstr
import
connect
viral
amplif
effici
score
ae
optim
probe
select
final
describ
new
statisticsbas
pathogen
detect
algorithm
pda
link
togeth
permit
confid
identif
organ
entir
predict
evalu
entir
platform
relat
convent
pcr
techniqu
cohort
patient
lower
respiratori
ill
systemat
investig
dynam
arraybas
pathogen
detect
creat
oligonucleotid
array
use
nimblegen
array
synthesi
technolog
array
design
detect
rna
virus
use
probe
tile
averag
resolut
across
full
length
genom
probe
figur
tabl
addit
data
file
togeth
replic
viral
probe
control
sequenc
array
synthesi
hybrid
see
materi
method
array
contain
total
probe
initi
studi
viru
sampl
purifi
cell
line
reversetranscrib
pcramplifi
virusspecif
primer
instead
random
primer
allow
us
studi
array
hybrid
dynam
control
fashion
without
complex
crosshybrid
human
rna
random
anneal
dynam
occur
random
primer
appli
find
clinic
sampl
amplifi
use
random
primer
sar
coronaviru
dengu
serotyp
genom
cdna
amplifi
entireti
confirm
sequenc
label
hybrid
separ
microarray
sar
sampl
hybrid
well
sar
tile
probe
sarsspecif
probe
display
fluoresc
signal
well
detect
threshold
determin
probe
signal
intens
standard
deviat
sd
mean
array
signal
intens
figur
crosshybrid
pathogen
probe
set
minim
observ
member
coronavirida
speci
picornavirida
paramyxovirida
consist
observ
sar
share
littl
sequenc
homolog
known
virus
hybrid
pattern
dengu
hand
complex
figur
first
observ
hybrid
dengu
probe
set
partial
incomplet
region
absent
signal
due
sequenc
polymorph
dengu
sampl
hybrid
array
cultur
hawaiian
isol
wherea
array
probe
set
base
sequenc
singaporean
strain
isol
sequenc
entir
genom
isol
reveal
array
probe
fail
hybrid
contain
least
mismatch
within
stretch
sampl
sequenc
second
observ
crosshybrid
occur
degre
almost
viral
probe
set
present
array
particularli
probe
flavivirida
member
consist
fact
dengu
serotyp
share
homolog
understand
relationship
hybrid
signal
output
anneal
specif
first
compar
probe
sequenc
viral
genom
use
two
measur
similar
probe
ham
distanc
hd
maximum
contigu
match
mcm
hd
measur
overal
similar
distanc
two
sequenc
low
score
similar
sequenc
mcm
measur
number
consecut
base
exact
match
high
score
similar
sequenc
calcul
hd
mcm
score
everi
probe
rel
hawaiian
dengu
isol
observ
score
correl
neg
hd
posit
mcm
probe
signal
intens
figur
probe
array
high
similar
hawaiian
dengu
genom
hd
n
mcm
n
hybrid
median
signal
intens
sd
detect
threshold
although
probe
detect
low
hd
rang
high
mcm
rang
median
probe
signal
intens
decreas
everi
increment
sequenc
distanc
figur
median
signal
intens
drop
sharpli
background
level
hd
mcm
detect
probe
respect
major
probe
n
hd
score
andor
mcm
score
respect
detect
optim
similar
threshold
hd
mcm
probe
could
detect
median
signal
intens
sd
detect
threshold
wherea
adjust
similar
threshold
step
hd
mcm
would
result
approxim
probe
detect
median
signal
intens
approxim
sd
detect
threshold
figur
use
optim
hd
mcm
threshold
guard
crosshybrid
bin
probe
specif
recognit
signatur
probe
set
rsignatur
like
specif
detect
given
pathogen
defin
rsignatur
pathogen
genom
repres
array
tabl
pathogen
rsignatur
compris
tile
probe
deriv
genom
sequenc
hd
mcm
well
crosshybrid
probe
deriv
pathogen
hd
mcm
accord
criteria
given
probe
could
belong
multipl
differ
rsignatur
therebi
maxim
probelevel
evid
pathogen
detect
next
consid
nonspecif
hybrid
phenomena
could
affect
perform
rsignatur
probe
exampl
observ
linear
relationship
probe
signal
gc
content
data
shown
consist
previou
observ
found
probe
gc
hybrid
diminish
signal
intens
probe
gc
content
show
higher
signal
intens
thu
censor
probe
gc
rsignatur
despit
optim
hd
mcm
valu
furthermor
crosshybrid
human
sequenc
could
also
confound
result
compar
probe
human
genom
assembl
build
blast
use
word
size
probe
expect
valu
also
censor
tabl
ideal
pathogen
rsignatur
would
one
probe
would
hybrid
target
sequenc
detect
level
polymorph
variat
probe
deriv
consensu
sequenc
actual
target
would
expect
imped
perform
rsignatur
probe
level
test
hypothesi
compar
ratio
detect
undetect
probe
across
rsignatur
context
hybrid
involv
hawaiian
dengu
isol
although
dengu
sequenc
use
deriv
dengu
rsignatur
approxim
differ
hawaiian
isol
detect
probe
ratio
dengu
specif
probe
time
higher
nearest
dengu
serotyp
signatur
suggest
moder
polymorph
variat
quit
toler
allow
case
discern
correct
pathogen
random
prime
amplif
rather
primerspecif
amplif
prefer
identifi
unknown
pathogen
clinic
specimen
howev
initi
experi
use
random
prime
amplif
identifi
known
pathogen
frequent
observ
incomplet
hybrid
pathogen
genom
mark
interspers
genom
region
detect
probe
exampl
involv
amplif
respiratori
syncyti
viru
rsv
b
human
nasopharyng
aspir
shown
figur
preliminari
analys
sequenc
polymorph
probe
gc
content
genom
secondari
structur
fail
explain
phenomenon
suggest
might
result
pcrbase
amplif
bia
stem
differenti
abil
random
primer
bind
viral
genom
revers
transcript
rt
step
random
primer
use
experi
compos
random
nonam
tag
fix
sequenc
intraprim
secondari
structur
format
dimer
hairpin
format
tag
nonam
probe
melt
temperatur
known
influenc
bind
effici
explor
hypothesi
design
algorithm
model
rtpcr
process
use
experiment
data
see
addit
data
file
detail
briefli
calcul
probabl
basepair
product
averag
size
rang
pcr
product
gener
possibl
start
posit
genom
assum
nonam
random
primer
mix
complement
viral
sequenc
perfectli
probabl
reduc
intraprim
hairpin
format
predict
increas
accord
degre
complementar
tag
sequenc
viral
sequenc
manner
probabl
nucleotid
success
pcramplifi
reflect
ae
see
supplement
method
addit
data
file
valid
algorithm
rank
hybrid
signal
intens
probe
tile
across
rsv
b
genom
compar
ae
valu
figur
observ
high
ae
significantli
correl
probe
hybrid
signal
intens
detect
threshold
p
fisher
exact
test
anoth
experi
involv
patient
sampl
posit
metapneumoviru
hmpv
probe
tile
across
hmpv
genom
show
similar
result
p
repeatedli
observ
higher
ae
correl
greater
probe
detect
averag
detect
probe
top
ae
see
supplement
method
addit
data
file
hd
mcm
gc
sequenc
uniqu
valuabl
paramet
probe
select
take
account
pcr
bia
insuffici
predictor
probe
perform
consid
absenc
ae
figur
found
use
probe
within
top
ae
tabl
substanti
improv
efficaci
predict
algorithm
discuss
follow
section
total
appli
probe
select
criteria
rsignatur
util
uniqu
probe
initi
includ
array
next
hypothes
amplif
effici
score
could
use
select
optim
tag
sequenc
rtpcr
primer
achiev
uniformli
high
ae
across
viral
genom
thu
global
maxim
pcr
effici
see
supplement
method
addit
data
file
briefli
gener
primer
sequenc
elimin
form
selfdim
calcul
ae
everi
genom
base
candid
primer
tag
primer
highest
averag
ae
virus
present
array
select
aesoptim
primer
compar
studi
eight
patient
sampl
five
rsv
three
hmpv
observ
primer
show
mark
improv
overal
pcr
effici
amplifi
rsv
hmpv
origin
primer
figur
addit
data
file
increas
pcr
effici
contribut
increas
hybrid
dna
probe
reflect
uniformli
higher
signal
intens
observ
use
primer
consequ
viral
probe
signal
intens
detect
threshold
use
primer
compar
approxim
use
primer
anova
test
p
figur
addit
data
file
observ
signal
intens
pathogen
rsignatur
approxim
normal
distribut
larg
proport
probe
compris
signatur
detect
pathogen
rel
strong
signal
intens
result
rightskew
distribut
figur
reason
analysi
tail
signal
intens
distribut
rsignatur
might
better
enabl
identif
infect
pathogen
also
presenc
coinfect
pathogen
sampl
thu
devis
robust
statisticsbas
pda
analyz
distribut
probe
signal
intens
rel
silico
rsignatur
see
supplement
method
addit
data
file
pda
softwar
compris
two
part
evalu
signal
intens
probe
pathogen
rsignatur
use
modifi
kullbackleibl
diverg
kl
statist
analysi
modifi
kl
score
use
andersondarl
test
sinc
origin
kl
reliabl
determin
differ
tail
probabl
distribut
highli
depend
number
probe
per
genom
size
signal
intens
bin
incorpor
andersondarl
statist
give
weight
tail
distribut
use
cumul
distribut
function
instead
origin
probabl
distribut
p
valu
gener
independ
bin
criteria
elimin
error
occur
particular
signal
intens
bin
empti
call
modifi
kl
diverg
weight
kullbackleibl
diverg
wkl
w
k
l
p
p
j
k
q
j
log
q
j
q
j
q
j
q
j
mathtyp
mtef
qa
j
cumul
distribut
function
signal
intens
probe
pa
found
bin
bj
j
mathtyp
mtef
cumul
distribut
function
signal
intens
probe
mathtyp
mtef
found
bin
bj
rsignatur
repres
absent
pathogen
normal
signal
intens
distribut
thu
rel
low
wkl
score
wherea
repres
present
pathogen
high
statist
signific
outli
wkl
score
figur
second
part
pda
distribut
wkl
score
subject
andersondarl
test
normal
p
wkl
distribut
consid
normal
impli
pathogen
outli
wkl
score
present
upon
identif
pathogen
pathogen
wkl
score
left
separ
andersondarl
test
perform
test
presenc
coinfect
pathogen
manner
procedur
iter
appli
normal
distribut
remain
p
pda
algorithm
extrem
fast
capabl
make
diagnosi
hybrid
microarray
less
second
assess
clinic
util
pathogen
predict
platform
analyz
nasal
wash
specimen
accord
workflow
illustr
figur
specimen
obtain
children
year
age
lower
respiratori
tract
infect
lrti
hospit
sever
diseas
ambulatori
lrti
clinic
diagnosi
patient
bronchiol
pneumonia
specimen
previous
analyz
presenc
hmpv
rsv
b
use
realtim
pcr
twentyon
specimen
test
posit
one
virus
fifteen
pcrneg
three
specimen
analyz
microarray
blind
fashion
tabl
rsv
fullgenom
sequenc
publish
array
design
specif
detect
viru
thu
first
assess
array
perform
use
result
patient
diagnos
either
hmpv
rsv
b
pcr
tabl
cohort
microarray
correctli
detect
presenc
hmpv
rsv
b
sampl
correspond
assay
specif
sensit
diagnost
accuraci
fals
neg
sampl
patient
ct
valu
near
detect
limit
realtim
pcr
thu
perhap
beyond
rang
detect
microarray
next
assess
array
perform
group
patient
pcrposit
rsv
n
pcrneg
test
virus
n
microarray
made
two
posit
call
group
rsv
b
interestingli
rsv
b
call
correspond
hightitr
rsv
specimen
pcr
patient
suggest
certain
probe
set
detect
presenc
relat
unspecifi
virus
analysi
publish
rsv
partial
genom
sequenc
bp
genbank
id
reveal
probe
microarray
ident
rsv
creat
rsv
rsignatur
compris
probe
enabl
specif
detect
rsv
microarray
patient
sampl
pcrposit
rsv
patient
although
perform
small
rsignatur
robust
viru
rsignatur
median
size
probe
suggest
feasibl
pursu
viral
discoveri
approach
use
rsignatur
creat
detect
virus
famili
genu
level
relat
speci
alreadi
repres
microarray
specif
bin
probe
famili
genuslevel
rsignatur
relax
similar
criteria
hd
mcm
select
probe
common
genom
sequenc
within
famili
genera
picornavirida
famili
paramyxovirida
famili
rhinoviru
genu
hrv
pneumoviru
genu
inclus
rsv
hmpv
upon
reanalysi
sampl
identifi
presenc
pneumoviru
specimen
expect
fals
posit
patient
addit
detect
presenc
hrv
specimen
tabl
hrv
novel
discoveri
rescreen
sampl
pcr
found
hrv
specimen
nine
hrv
call
microarray
confirm
pcr
except
one
find
intrigu
given
genom
divers
known
rhinoviru
serotyp
make
detect
pcr
notori
difficult
realtim
pcr
primer
capabl
identifi
approxim
rhinoviru
strain
possibl
microarray
correctli
detect
rhinoviru
strain
pcr
fail
detect
similarli
pneumoviru
genu
detect
patient
could
verifi
rtpcr
possibl
owe
subtl
genet
variat
prevent
primer
anneal
thu
greater
genom
coverag
afford
microarray
might
case
provid
sensit
accur
detect
capabl
pathogenspecif
pcr
though
microarray
identifi
major
hrv
rsv
sampl
use
genuslevel
rsignatur
fail
detect
three
sampl
posit
hrv
three
posit
rsv
realtim
pcr
fals
neg
averag
ct
valu
suggest
detect
threshold
close
realtim
pcr
howev
microarray
also
made
number
accur
discoveri
ct
rang
suggest
consider
degre
detect
variabl
titr
rang
approxim
ct
equival
notabl
microarray
correctli
detect
presenc
coinfect
pathogen
two
sampl
demonstr
uniqu
potenti
microarray
platform
reveal
complex
diseas
etiolog
though
pathogen
detect
microarray
young
field
number
differ
platform
approach
describ
import
attribut
exampl
array
describ
wang
et
al
base
probe
design
recogn
conserv
viral
domain
facilit
detect
taxonom
fingerprint
provid
power
clue
viral
ident
minim
probe
usag
lin
et
al
hand
describ
probedens
resequenc
array
capabl
detect
smaller
set
predefin
pathogen
higher
detect
specif
includ
abil
discern
highli
relat
subtyp
microarray
describ
herein
repres
blend
two
concept
integr
probe
tile
approach
substanti
genom
coverag
though
lower
probe
densiti
resequenc
array
taxonomybas
strategi
bin
probe
pathogen
recognit
signatur
thu
analyt
output
includ
famili
genuslevel
predict
rsignatur
restrict
conserv
probe
well
speciesspecif
predict
rsignatur
compos
conserv
uniqu
probe
inde
capabl
allow
us
detect
accur
identifi
virus
clinic
sampl
tabl
central
pathogen
predict
algorithm
weigh
microarray
data
predefin
recognit
signatur
unfortun
algorithm
exist
one
algorithm
epredict
report
valid
epredict
match
hybrid
signatur
predict
pathogen
signatur
deriv
theoret
free
energi
hybrid
microarray
probe
examin
perform
epredict
microarray
platform
analyz
number
sampl
epredict
pda
algorithm
appli
microarray
data
epredict
perform
well
first
predict
tend
correct
one
tabl
addit
data
file
howev
specimen
number
fals
posit
call
also
made
seem
reflect
speci
consider
sequenc
similar
true
infect
pathogen
tabl
addit
data
file
exampl
patient
sampl
epredict
detect
rsv
correct
pathogen
also
multipl
speci
coronaviru
share
sequenc
similar
rsv
yet
realtim
pcr
use
pancoronaviru
primer
well
primer
specif
strain
indic
absenc
coronaviru
sampl
figur
addit
data
file
fals
posit
call
explain
fact
function
epredict
less
gear
toward
identifi
distinguish
specif
pathogen
strain
aim
elucid
best
possibl
candid
support
avail
probe
thu
epredict
particularli
advantag
situat
pathogen
sequenc
fulli
known
contrast
pda
algorithm
design
make
call
greater
specieslevel
resolut
major
strength
pda
abil
specif
identifi
sequencecharacter
coinfect
pathogen
low
fals
posit
aptli
demonstr
abil
pda
detect
specif
presenc
dengu
clinic
sampl
virus
array
flavivirida
famili
includ
dengu
serotyp
share
sequenc
homolog
benefit
use
algorithm
simultan
detect
known
novel
pathogen
evalu
import
discoveri
studi
composit
random
primer
tag
signific
impact
effici
viral
genom
amplif
assess
amplif
effici
score
measur
amplif
effici
allow
us
predict
probe
would
provid
inform
recognit
signatur
markedli
improv
pathogen
predict
capabl
moreov
find
allow
us
design
aesoptim
primer
increas
amplif
effici
sampl
result
greater
sensit
pathogen
detect
whether
multiplex
rtpcr
use
varieti
aesdesign
primer
tag
increas
amplif
effici
warrant
investig
addit
feasibl
tagbas
pcr
applic
gener
dna
librari
enrich
rna
resequenc
may
benefit
primer
optim
use
ae
algorithm
dna
microarray
potenti
revolution
clinic
diagnost
abil
simultan
investig
thousand
potenti
pathogen
order
make
diagnosi
howev
question
remain
regard
sensit
reliabl
work
investig
myriad
factor
influenc
microarray
perform
context
viru
detect
clinic
specimen
describ
optim
platform
capabl
identifi
individu
coinfect
virus
high
accuraci
sensit
bring
microarray
technolog
closer
clinic
futur
improv
includ
signific
reduct
microarray
manufactur
usag
cost
multiplex
microarray
format
reusabl
array
develop
technolog
promis
drive
cost
furthermor
altern
technolog
bead
microfluid
nanotub
microarray
might
provid
advantag
assay
cost
speed
rel
tradit
microarray
platform
technolog
consider
asid
advantag
highli
parallel
nucleic
acidbas
screen
approach
detect
diseas
pathogen
clear
valid
larger
patient
cohort
divers
clinic
set
import
next
step
toward
establish
clinic
role
pathogen
detect
microarray
complet
genom
sequenc
clinic
relev
human
virus
tabl
addit
data
file
download
ncbi
taxonomi
databas
use
gener
probe
sequenc
tile
across
genom
overlap
averag
resolut
seven
replic
probe
synthes
random
posit
microarray
use
nimblegen
proprietari
technolog
qualiti
control
purpos
random
sequenc
probe
gc
content
includ
assess
background
signal
level
addit
control
includ
probe
human
immun
gene
posit
control
probe
plant
viru
pmmv
neg
control
total
probe
synthes
array
dengu
atcc
cultur
per
atcc
recommend
sar
cultur
describ
clinic
specimen
nasopharyng
wash
obtain
indonesian
pediatr
popul
use
standard
protocol
describ
patient
age
month
show
symptom
lrti
diagnos
bronchiol
pneumonia
visit
clinic
februari
februari
patient
subsequ
hospit
sampl
store
rnazol
leedo
medic
laboratori
inc
friendswood
tx
usa
rna
later
extract
sampl
rnazol
accord
manufactur
instruct
resuspend
rna
storag
solut
ambion
inc
austin
tx
usa
frozen
use
detail
protocol
provid
supplement
method
addit
data
file
briefli
rna
revers
transcrib
cdna
use
tag
random
primer
describ
origin
primer
gtttcccagtcacgatannnnnnnnn
aesoptim
primer
gatgagggaagatggggnnnnnnnnn
cdna
amplifi
random
pcr
fragment
endlabel
biotin
hybrid
onto
microarray
stain
previous
describ
except
addit
tetramethylammonium
chlorid
tmac
nimblegen
hybrid
buffer
minim
nonspecif
hybrid
reaction
mixtur
contain
purifi
patient
rna
u
mulv
revers
transcriptas
u
recombin
rnase
inhibitor
univers
pcr
master
mix
ung
appli
biosystem
foster
citi
ca
usa
combin
primer
rsv
b
hmpv
hrv
rsv
probe
primer
probe
sequenc
hmpv
primer
probe
rsv
hrv
describ
sampl
underw
revers
transcript
minut
heat
minut
amplifi
cycl
minut
abi
prism
sequenc
detect
system
appli
biosystem
amplif
fluoresc
emiss
monitor
everi
thermal
cycl
threshold
ct
repres
cycl
signific
fluoresc
first
detect
ct
valu
convert
copi
number
use
control
plasmid
known
concentr
rsv
copi
ct
valu
rsv
b
copi
ct
valu
hmpv
copi
ct
valu
hrv
copi
ct
valu
frozen
live
cultur
human
coronaviru
purchas
atcc
cat
use
posit
control
rna
extract
cultur
use
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
sampl
amplifi
use
diagnost
primer
pair
pancoronaviru
previous
describ
microarray
scan
resolut
use
axon
scanner
genepix
softwar
molecular
devic
sunnyval
ca
usa
signal
intens
extract
use
nimblescan
softwar
nimblegen
system
madison
wi
usa
use
autom
script
j
georg
v
vega
calcul
median
signal
intens
standard
deviat
seven
replic
probe
probe
signal
intens
sort
genom
arrang
sequenc
order
reformat
cdt
format
graphic
view
signal
intens
java
treeview
parallel
probe
median
signal
intens
analyz
use
pda
determin
pathogen
present
associ
confid
level
predict
ae
pda
algorithm
describ
detail
result
section
algorithm
formula
softwar
microarray
data
avail
supplement
websit
addit
data
file
follow
addit
data
avail
onlin
version
paper
addit
data
file
includ
supplementari
materi
method
figur
tabl
pathogen
microarray
data
softwar
